Biocept (BIOC) Reports Q4 Loss of $0.87/Share

Biocept (NASDAQ: BIOC) reported Q4 EPS of ($0.87), versus ($13.57) reported last year. Revenue for the quarter came in at $76 thousand, versus $19 thousand reported last year.

For earnings history and earnings-related data on Biocept (BIOC) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Fabrinet (FN) Tops Q4 EPS by 29c, Beats on Revenue; Offers Guidance
• INVO Fertility (IVF) Tops Q2 EPS by 105c